Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice. [electronic resource]
- Cancer chemotherapy and pharmacology Aug 2008
- 457-64 p. digital
Publication Type: Journal Article
0344-5704
10.1007/s00280-007-0625-2 doi
Administration, Oral Animals Biological Availability Chromatography, Liquid Cytidine Deaminase--antagonists & inhibitors Enzyme Inhibitors--blood Half-Life Injections, Intravenous Male Mice Mice, Inbred Strains Protein Binding Tandem Mass Spectrometry Tetrahydrouridine--blood